Literature DB >> 9694064

Acute transverse myelitis and primary urticarial vasculitis.

G Bolla1, P Disdier, D Verrot, L Swiader, L Andrac, J R Harlé, J Pouget, P J Weiller.   

Abstract

We report the case of a 56-year-old man with severe normocomplementaemic primary urticarial vasculitis for 16 years. Nine and 11 years after the onset of the symptoms, he developed two severe neurological complications, seizure and transverse myelitis, that must be attributed to the vasculitis. Transverse myelitis has been reported in other systemic diseases, particularly lupus erythematosus, but this is the first case of transverse myelitis complicating urticarial vasculitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694064     DOI: 10.1007/bf01451059

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  Rheumatoid arthritis, transverse myelitis and antiphospholipid antibodies.

Authors:  H L Staub; K Capobianco; P R Neto; M Keiserman
Journal:  Clin Exp Rheumatol       Date:  1992 Nov-Dec       Impact factor: 4.473

2.  Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations, and treatment.

Authors:  R A Asherson; D D'Cruz; C J Stephens; P H McKee; G R Hughes
Journal:  Semin Arthritis Rheum       Date:  1991-04       Impact factor: 5.532

3.  The Canadian Rheumatism Association, 1991 Dunlop-Dottridge Lecture. Vasculitis, 1815 to 1991: classification and diagnostic specificity.

Authors:  J T Lie
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

Review 4.  Urticarial vasculitis and syndromes in association with connective tissue diseases.

Authors:  R A Asherson; R Sontheimer
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

6.  Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.

Authors:  C Lavalle; S Pizarro; C Drenkard; J Sánchez-Guerrero; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1990-01       Impact factor: 4.666

7.  Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1994-02

Review 8.  Urticarial vasculitis: a histopathologic and clinical review of 72 cases.

Authors:  D R Mehregan; M J Hall; L E Gibson
Journal:  J Am Acad Dermatol       Date:  1992-03       Impact factor: 11.527

9.  [Seronegative leukocytoclastic vasculitis preceding the onset of disseminated systemic lupus erythematosus].

Authors:  X Chevalier; N Belmatoug; M F Kahn
Journal:  Rev Rhum Mal Osteoartic       Date:  1990-11

Review 10.  Clinical manifestations of the antiphospholipid syndrome.

Authors:  D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1992-11       Impact factor: 4.666

View more
  3 in total

Review 1.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 2.  [Differential diagnostics of autoimmune inflammatory spinal cord diseases].

Authors:  Frederike C Oertel; Michael Scheel; Claudia Chien; Antje Bischof; Carsten Finke; Friedemann Paul
Journal:  Nervenarzt       Date:  2021-03-25       Impact factor: 1.214

Review 3.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.